Abstract

Background(123)-I-2-ß-carbomethoxy-3ß-(4-iodophenyl)-N-(3-fluoropropyl) nortro- pane single photon emission computed tomography (123I-FP-CIT SPECT) was validated to distinguish Alzheimer’s dementia from dementia with Lewy Bodies (DLB) by European medical agencies. Little evidence exists that validates 123 I-FP-CIT SPECT as a supplementary method to diagnose probable DLB in a psychiatric cohort of patients with psychiatric symptomatology and suspected DLB. We aim to elucidate differences in the clinical phenotype of DLB between those patients with and those without a positive 123 I-FP-CIT SPECT indicating a nigrostriatal deficit.MethodsTo investigate this, we included 67 patients from the Department of Psychiatry and Psychotherapy at University Medical Center Göttingen (UMG) in our study who had undergone 123I-FP-CIT SPECT in the Department of Nuclear Medicine (UMG) by evaluating their patient files.Results55% with a positive-123I-FP-CIT SPECT and probable DLB after the 123I-FP-CIT SPECT exhibited psychiatric features. The number of probable DLB patients in those exhibiting psychiatric symptoms was higher post-123I-FP-CIT SPECT than pre-123I-FP-CIT SPECT assessed cross-sectionally over a 6-year period (p < 0.05). In addition, prodromal DLB and prodromal DLB patients with a psychiatric-phenotype yielded higher numbers post-123I-FP-CIT SPECT than pre-123I-FP-CIT SPECT (p < 0.05). Furthermore, we discovered no phenotypical differences between those DLB patients with a positive and those with a negative 123I-FP-CIT SPECT. 123I-FP-CIT SPECT-positive DLB patients in our psychiatric cohort revealed a psychiatric onset more often (52%); DLB was less often characterized by an MCI onset (26%) (p < 0.005).ConclusionsOur findings support 123I-FP-CIT SPECT as an adjuvant tool for improving the diagnosis of probable DLB and prodromal DLB in a cohort of psychiatric patients with often concomitant psychiatric symptomatology. The psychiatric-onset is more frequent than an MCI-onset in DLB patients presenting nigrostriatal dysfunction, giving us an indication of the relevance of deep clinical phenotyping in memory clinics that includes the assessment of psychopathology.

Highlights

  • Dementia with Lewy bodies (DLB) is a frequent neurodegenerative dementia occurring in about 8% of all dementia patients (Walker et al, 2015)

  • Probable DLB patients underwent 123-FP-CIT SPECT with the aim of confirming a probable DLB diagnosis— that is, where we harbored doubts about the diagnosis, or about core clinical features derived from the patient history

  • MRI was performed in 42 DLB patients (n = 24 with a psychiatric-onset, n = 7 with an mild cognitive impairment (MCI)-onset, and in n = 11 with mixed-onset); and 14 patients underwent EEG (n = 7 with psychiatric-onset, n = 2 MCI-onset, and n = 5 mixed-DLB onset)

Read more

Summary

Introduction

Dementia with Lewy bodies (DLB) is a frequent neurodegenerative dementia occurring in about 8% of all dementia patients (Walker et al, 2015). Lewy body pathology has been frequently detected coincidentally post-mortem in patients without dementia (Wakisaka et al, 2003) As these studies reveal a mismatch between diagnosis during life and post-mortem, we should be aiming to improve the early diagnosis of DLB. In addition to the disease’s core clinical features, supportive criteria for diagnosing DLB are psychiatric features like delusions, other hallucinations, apathy, fear, or depression according to McKeith et al (2017). Potential DLB can be diagnosed if no core clinical feature is identified, but if the indicative biomarker (123)I-2-ß-carbomethoxy-3ß-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography (123I-FP-CIT SPECT) reveals a uni-or bilateral nigrostriatal deficit, it is a positive result. Supporting psychiatric features can lead to a possible DLB diagnosis if the 123I-FP-CIT SPECT is positive. Supporting psychiatric features can lead to a possible DLB diagnosis if the 123I-FP-CIT SPECT is positive. 123I-FP-CIT

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call